Journals / Annals of Medical Research / 2021 / Cilt: 28 - Sayı: 9

Awareness of cervical cancer, human papilloma virus (HPV) and HPV vaccination among women in a cancer screening, early diagnosis and education center

Pages
1735–1741
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Participants with higher education levels had significantly higher Pap smear test knowledge and performed more Pap smear tests than those who had lower education levels (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: This study was conducted to assess the awareness of women about cervical cancer and human papilloma virus (HPV) and to evaluate their HPV DNA test results.
📊
Key Findings & Data:Materials and Methods: This analytical cross-sectional study was conducted in 250 women who applied to Cancer Early Diagnosis Screening and Training Center (KETEM) at Konya Training and Research Hospital of Health Sciences University.
💡
Conclusion & Impact:Participants with higher education levels had significantly higher Pap smear test knowledge and performed more Pap smear tests than those who had lower education levels (p
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: This study was conducted to assess the awareness of women about cervical cancer and human papilloma virus (HPV) and to evaluate their HPV DNA test results. Materials and Methods: This analytical cross-sectional study was conducted in 250 women who applied to Cancer Early Diagnosis Screening and Training Center (KETEM) at Konya Training and Research Hospital of Health Sciences University. A questionnaire prepared by the researchers was applied to determine the women's sociodemographic characteristics, cervical cancer and HPV knowledge levels. Results: The mean age of the women was 47.7 ± 7.5 years old. When the smear results of the women included in the study are examined, HPV was positive in 3.2% (n=8). Participants with higher education levels had significantly higher Pap smear test knowledge and performed more Pap smear tests than those who had lower education levels (p

🔖

Cite This Article

Kutlu, R., Eryilmaz, M. A., Erdogan, M., Cihan, F. G. (2022). Awareness of cervical cancer, human papilloma virus (HPV) and HPV vaccination among women in a cancer screening, early diagnosis and education center. Annals of Medical Research, Cilt: 28 - Sayı: 9, 1735–1741. https://ajindex.com/articles/445915

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. WHO 2014. World Health Organization. Comprehensive Cervical Cancer Control: A Guide to Essential Practice. Geneva, Switzerland: World Health Organization. https://www.who.int/reproductivehealth/ publications/cancers/cervical-cancer-guide/en/ 2. Turkey Cancer Control Program. “Turkish Ministry of Health Cancer Department 2010" http://kanser. gov.tr/Dosya/NCCP_2013-2018.pdf Access date: 04.01.2017. 3. Kitchener H. Optimising future cervical screening strategies. Papillomavirus Res 2019;7:201-3. 4. Turazza E, Lapena A, Sprovieri O, et al. Low risk human papillomavirus types 6 and 11 associated with carcinomas of the 71 genital and upper aero- digestive tract. Acta Obstet Gynecol Scand 1997;76:271-6. 5. Lazzari CM, Krug LP, Quadros OF, et al. Human papillomavirus frequency in oral epithelial lesions. J Oral Pathol Med 2004;33:260-5. 6. Gómez DT, Santos JL. Communicating Current Research and Educational Topics and Trends in Applied Microbiology A. Ed. Méndez-Vilas. Formatex; 2007:680-8. 7. Uyar D, Rader J. Genomics of cervical cancer and the role of Human Papillomavirus pathobiology. Clin Chem 2014; 60:1-3. 8. Parkin DM, Bray F. Chapter 2: The burden of HPVrelated cancers. Vaccine 2006;24:11-25. 9. Dunder I, Kahraman K. Cost Issue in Cervical Cancer and Expected Outcomes of the HPV Vaccines. Turkish Clinics J Gynecol Obst-Special Topics 2009;2:69-77. 10. Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:63- 73. 11. Dursun P, Senger SS, Arslan H, et al. Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis 2009;9:191. 12. Kline TS. The Papanicolaou smear: a brief historical perspective and where we are today. Arch Pathol Lab Med 1997;121:205-9. 13. Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med 2008;5:e132. 14. Cancer Screening Brief Report 2014. http://kanser. gov.tr/kanser/kanser-taramalari/1444-kansertaramalar%C4%B1-k%C4%B1sa-rapor-2014.html Access date: 28.07.2017 15. Global Adult Tobacco Survey (GATS)-2016 http:// www.halksagligi.hacettepe.edu.tr/duyurular/ halkayonelik/kyta2016.pd. Access date: 28.07.2019 16. Bruni L, Diaz M, Castellsagué X, et al. Cervical human papillomavirus prevalence in 5 continents: metaanalysis of 1 million women with normal cytological findings. J Infect Dis 2010;202:1789-99. 17.